Ultrasound-activated erythrocyte membrane-camouflaged Pt (II) layered double hydroxide enhances PD-1 inhibitor efficacy in triple-negative breast cancer through cGAS-STING pathway-mediated immunogenic cell death.

Saved in:
Bibliographic Details
Title: Ultrasound-activated erythrocyte membrane-camouflaged Pt (II) layered double hydroxide enhances PD-1 inhibitor efficacy in triple-negative breast cancer through cGAS-STING pathway-mediated immunogenic cell death.
Authors: Wu Y; School of Science and Engineering, Shenzhen Key Laboratory of Innovative Drug Synthesis, The Chinese University of Hong Kong, Shenzhen, 518172, China., Zhao Z; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.; Thomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC, 27708, USA., Ma M; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China., Zhang W; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China., Liu W; The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, 510026, China., Liang X; Environmental Toxicology, University of California, Riverside, CA, 92507, USA., Zhao T; Environmental Toxicology, University of California, Riverside, CA, 92507, USA., Luo Y; Institute of Immunotherapy, School of Basic Medicine, Fujian Medical University, Fuzhou, 350122, China., Wang Y; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China., Li M; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China., Li T; Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China., Liu C; Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China., Luo X; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China., Wang S; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China., Li W; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China., Zeng W; Department of Gastroenterology, Department of Obstetrics and Gynecology, Affiliated Xiang'an Hospital, Medical Center, Xiamen University, 361000, China., Wang H; Department of Gastroenterology, Department of Obstetrics and Gynecology, Affiliated Xiang'an Hospital, Medical Center, Xiamen University, 361000, China., Li W; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China., Wu T; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China., Ke Z; School of Science and Engineering, Shenzhen Key Laboratory of Innovative Drug Synthesis, The Chinese University of Hong Kong, Shenzhen, 518172, China., Luo F; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Source: Theranostics [Theranostics] 2025 Jan 02; Vol. 15 (4), pp. 1456-1477. Date of Electronic Publication: 2025 Jan 02 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1838-7640
DOI:10.7150/thno.102284